168 related articles for article (PubMed ID: 23407925)
1. Efficacy of adalimumab for the treatment of refractory paediatric acrodermatitis continua of hallopeau.
Dini V; Barbanera S; Romanelli M
Acta Derm Venereol; 2013 Sep; 93(5):588-9. PubMed ID: 23407925
[No Abstract] [Full Text] [Related]
2. Treatment of acrodermatitis continua of Hallopeau with adalimumab.
Ryan C; Collins P; Kirby B; Rogers S
Br J Dermatol; 2009 Jan; 160(1):203-5. PubMed ID: 18945314
[No Abstract] [Full Text] [Related]
3. Adalimumab for a co-existing clinical condition of Crohn's disease and acrodermatitis continua of Hallopeau.
Caputo F; Parro S; Zoli G
J Crohns Colitis; 2011 Dec; 5(6):649. PubMed ID: 22115391
[No Abstract] [Full Text] [Related]
4. Treatment of acrodermatitis continua of hallopeau with ixekizumab.
Miller AC; Holland TE; Cohen DJ
J Dermatolog Treat; 2021 Feb; 32(1):117-119. PubMed ID: 31184530
[TBL] [Abstract][Full Text] [Related]
5. Acrodermatitis continua of Hallopeau (ACH): two cases successfully treated with adalimumab.
Di Costanzo L; Napolitano M; Patruno C; Cantelli M; Balato N
J Dermatolog Treat; 2014 Dec; 25(6):489-94. PubMed ID: 24215490
[TBL] [Abstract][Full Text] [Related]
6. Successful treatment of recalcitrant acrodermatitis continua of Hallopeau with adalimumab and acitretin.
Tobin AM; Kirby B
Br J Dermatol; 2005 Aug; 153(2):445-6. PubMed ID: 16086767
[No Abstract] [Full Text] [Related]
7. Adalimumab treatment for acrodermatitis continua of Hallopeau: three cases refractory to IL-17 inhibition.
Zhang Z; Wu X; Han C; Chen M; Liu Y
J Dtsch Dermatol Ges; 2023 Jul; 21(7):785-787. PubMed ID: 37186059
[No Abstract] [Full Text] [Related]
8. A case of pediatric acrodermatitis continua of Hallopeau successfully treated with adalimumab biosimilar.
Megna M; Fabbrocini G; Costa C; Ferrillo M
Dermatol Ther; 2020 May; 33(3):e13327. PubMed ID: 32220123
[No Abstract] [Full Text] [Related]
9. Biologic therapy for acrodermatitis continua of Hallopeau: Successful treatment with secukinumab and review of the literature.
Galluzzo M; D'Adamio S; Teoli M; Bianchi L; Talamonti M
Dermatol Ther; 2019 May; 32(3):e12899. PubMed ID: 30969010
[TBL] [Abstract][Full Text] [Related]
10. Ustekinumab in the treatment of refractory chronic cutaneous lupus erythematosus: a case report.
Dahl C; Johansen C; Kragballe K; Olesen AB
Acta Derm Venereol; 2013 May; 93(3):368-9. PubMed ID: 23038045
[No Abstract] [Full Text] [Related]
11. Effectiveness of brodalumab in acrodermatitis continua of Hallopeau: A case report.
Passante M; Dastoli S; Nisticò SP; Bennardo L; Patruno C
Dermatol Ther; 2020 Jan; 33(1):e13170. PubMed ID: 31762153
[No Abstract] [Full Text] [Related]
12. A case of acrodermatitis continua of Hallopeau successfully treated with guselkumab.
Buononato D; Licata G; Gambardella A; De Rosa A; Calabrese G; Argenziano G
Dermatol Ther; 2022 Jul; 35(7):e15514. PubMed ID: 35420733
[No Abstract] [Full Text] [Related]
13. Acrodermatitis continua of Hallopeau successfully treated with ixekizumab: A case report.
Battista T; Guerrasio G; De Fata Salvatores G; Peduto T; Fabbrocini G; Di Guida A
Dermatol Ther; 2022 May; 35(5):e15383. PubMed ID: 35174591
[No Abstract] [Full Text] [Related]
14. Successful etanercept therapy in therapy refractory acrodermatitis continua suppurativa Hallopeau.
Weisshaar E; Diepgen TL
J Dtsch Dermatol Ges; 2007 Jun; 5(6):489-92. PubMed ID: 17537042
[TBL] [Abstract][Full Text] [Related]
15. A case of acrodermatitis continua of Hallopeau evolving into generalized pustular psoriasis successfully treated with guselkumab.
Yamamoto H; Kamiya K; Okada H; Maekawa T; Komine M; Ohtsuki M
Int J Dermatol; 2023 Feb; 62(2):269-270. PubMed ID: 35187654
[No Abstract] [Full Text] [Related]
16. Acrodermatitis Continua of Hallopeau with Psoriatic Arthritis.
Khosravi-Hafshejani T; Zhou Y; Dutz JP
J Rheumatol; 2019 Apr; 46(4):437-438. PubMed ID: 30936225
[No Abstract] [Full Text] [Related]
17. Etanercept responsive acrodermatitis continua of Hallopeau: is a pattern developing?
Bonish B; Rashid RM; Swan J
J Drugs Dermatol; 2006 Oct; 5(9):903-4. PubMed ID: 17039659
[TBL] [Abstract][Full Text] [Related]
18. A recalcitrant acrodermatitis continua of Hallopeau successfully treated with etanercept.
Silpa-archa N; Wongpraparut C
J Med Assoc Thai; 2011 Sep; 94(9):1154-7. PubMed ID: 21970208
[TBL] [Abstract][Full Text] [Related]
19. Ustekinumab for the treatment of acrodermatitis continua of Hallopeau refractory to anti-TNF agents.
Adışen E; Özer İ; Temel B; Gürer MA
Dermatol Ther; 2017 Mar; 30(2):. PubMed ID: 28139054
[TBL] [Abstract][Full Text] [Related]
20. Secukinumab for Acrodermatitis Continua of Hallopeau.
Muggli D; Maul JT; Anzengruber F; Fopp MW; Navarini AA
JAMA Dermatol; 2017 Apr; 153(4):336-337. PubMed ID: 28122071
[No Abstract] [Full Text] [Related]
[Next] [New Search]
